318549008: Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual medicinal product\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\UK product\Virtual therapeutic moiety\Nadolol + Bendroflumethiazide\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\UK product\Virtual therapeutic moiety\Nadolol + Bendroflumethiazide\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet

\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing nadolol\Product containing nadolol in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing adrenergic receptor antagonist (product)\Product containing beta adrenergic receptor antagonist\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing nadolol\Product containing nadolol in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing nadolol\Product containing nadolol in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing alcohol\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing bendroflumethiazide\Product containing bendroflumethiazide and nadolol\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Product manufactured as oral dose form\Product containing nadolol in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Product manufactured as oral dose form\Product containing bendroflumethiazide in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing nadolol\Product containing nadolol in oral dose form (medicinal product form)\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Nadolol + Bendroflumethiazide\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet
\Medicinal product\Product containing autonomic agent\Product containing beta adrenergic receptor antagonist\Product containing nadolol\Product containing bendroflumethiazide and nadolol\Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)\Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3680963018 Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module

3680964012 Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

46611501000001114 Nadolol 40mg / Bendroflumethiazide 5mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Is a	Nadolol+diuretic	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has active ingredient	Diuretic	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has active ingredient	Nadolol	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Is a	Product containing bendroflumethiazide and nadolol	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has active ingredient	Bendroflumethiazide	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has active ingredient	Bendrofluazide - chemical	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has manufactured dose form	Conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Is a	Product manufactured as oral dose form	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Is a	Product containing bendroflumethiazide and nadolol in oral dose form (medicinal product form)	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has active ingredient	Nadolol	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has basis of strength substance	Nadolol	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has presentation strength numerator value	40	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has active ingredient	Bendroflumethiazide	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has basis of strength substance	Bendroflumethiazide	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has presentation strength numerator value	5	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has unit of presentation	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has precise active ingredient	Bendroflumethiazide	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has precise active ingredient	Nadolol	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Is a	Product containing only bendroflumethiazide and nadolol in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Plays role	Diuretic therapeutic role	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has active ingredient	Nadolol	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has active ingredient	Bendroflumethiazide	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has unit of presentation	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has manufactured dose form	Conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route	tablet.oral ontology form and route	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration	Oral route	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has NHS dm+d (dictionary of medicines and devices) dose form indicator	Discrete dose form indicator	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has manufactured dose form	Oral dose form	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Is a	Nadolol + Bendroflumethiazide	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has unit of presentation	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has manufactured dose form	Conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has unit of presentation	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has manufactured dose form	Conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	VMP non-availability indicator	Not available	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has specific active ingredient	Nadolol	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has specific active ingredient	Bendroflumethiazide	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Is a	Virtual medicinal product	true	Inferred relationship	Existential restriction modifier
Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Nadolol+bendrofluazide 40mg/5mg tablet - product	Is a	False	Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)	Is a	True	Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet	Is pack of	False	Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Nadolol 40mg / Bendroflumethiazide 5mg tablets 28 tablet	Has VMP	True	Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3680963018	Bendroflumethiazide 5 mg and nadolol 40 mg oral tablet	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3680964012	Product containing precisely bendroflumethiazide 5 milligram and nadolol 40 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
46611501000001114	Nadolol 40mg / Bendroflumethiazide 5mg tablets	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom Edition module